ClinicalTrials.gg
Enrolling by invitationNCT07543211Updated Nov 17, 2026

Effectiveness of Laser Irradiation on the Veins and Acupoints on Arterial Stiffness in Patients With Cardio-renal Metabolic Syndrome

An observational study in Hypertension, Diabetes Mellitus and Chronic Kidney Disease, sponsored by National Yang Ming Chiao Tung University. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by National Yang Ming Chiao Tung University · Observational

How we know

Updated Nov 17, 2026Now Enrolling by invitationFirst site in Taiwan+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 117 studies in Hypertension with a site in Taiwan — 17 open to participants now, 21 under way, 5 of them phase 3. Hypertension · Taiwan.

Planned enrollment
21st of 25
35 · median 156
Started
2026
with 4 others
Observational
27 of 117
4 open now
Primary completion
2026-12
later than 5 of 20 live
Registered
114th of 117
by date

Among the 117 studies in Hypertension with a site in Taiwan, this one is the 21st largest by planned enrollment of the 25 observational ones that give a count, is one of 5 that started in 2026, is one of 27 observational ones, reaches primary completion later than 5 of the 20 other live ones, and was the 114th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

17 of the 117 studies in Hypertension with a site in Taiwan are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 117 studies in Hypertension with a site in Taiwan, or all of them as a file.
02

Study summary

Background: Cardio-renal metabolic syndrome (CRMS) is a vicious cycle of cardiac, renal, and metabolic disease, representing a high-risk for atherosclerosis. Laser acupuncture modulates vascular inflammation and improves endothelial function via low-level laser therapy (LLLT, \<500mW) at acupoints or musculoskeletal pain sites. Few studies have focused on CRMS populations. This study evaluates laser acupuncture effects on arterial stiffness in CRMS.

Purpose: To assess the effects of improvement of laser acupuncture in patients with CRMS, and to evaluate its feasibility as supportive therapy.

Methods: A single-group pre-post design is used. Participants are patients with CRMS receiving laser acupuncture at a Chinese medicine clinic in Taiwan. CRMS is interrelated by cardiac, renal, and metabolic disease. Inclusion criteria require diagnosis in ≥2 of 3 systems (cardiovascular, renal, or metabolic; n = 35). Laser acupuncture will be applied to bilateral BL40 for 12 weeks (1-3 sessions/week, 60mins/session). Pulse wave velocity(PWV) measured by Omron HBP- 8000 as the primary outcome for arterial stiffness. Paired t-tests and GEE will be used for analysis.

Expected Results: PWV is expected to show significant improvement after intervention.

03

Conditions studied

  • Hypertension
  • Diabetes Mellitus
  • Chronic Kidney Disease
  • Cardio-Renal-Metabolic Syndrome
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants are adult patients diagnosed with cardio-renal-metabolic syndrome who are receiving routine laser acupuncture treatment in a clinical setting. The study population includes individuals with conditions such as hypertension, diabetes mellitus, chronic kidney disease, or dyslipidemia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years or older
  2. Diagnosed with at least two conditions related to cardio-renal-metabolic syndrome (e.g., hypertension, diabetes mellitus, chronic kidney disease, or dyslipidemia)
  3. Receiving routine laser acupuncture treatment in a clinical setting
  4. Able to understand the study procedures and provide

Exclusion criteria

Exclusion Criteria:

  1. Presence of acute cardiovascular events (e.g., acute myocardial infarction, stroke)
  2. Acute kidney injury
  3. Presence of medical devices or conditions that contraindicate the use of laser acupuncture at the treatment site (e.g., arteriovenous shunt)
  4. Unable to complete the study procedures or follow-up assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (estimated)
Patient registry
No

Interventions

  • Otherlaser acupuncture

    Low-level laser therapy applied to acupuncture points as part of routine clinical treatment. No additional intervention is assigned for research purposes.

06

What researchers measure

Primary outcomes

  1. Change in Pulse Wave Velocity (PWV)

    Time frame: Baseline and after 12 weeks of treatment

07

Study locations

1 site
  • Yi-An Wu
    New Taipei City, Taipei 234, Taiwan
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.

Of 348 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's planned 7 months is below that.

Counting every sponsor, half of 429 studies reached it within 38 months; a quarter within 17 and three quarters within 96.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Aug 2026 → Dec 2026 and completion Oct 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2026
First posted
Apr 21, 2026
StartActual
May 1, 2026
Primary completionEst.
Dec 2026was Aug 2026
CompletionEst.
Dec 2026was Oct 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Nov 17, 2026
Sites
1 site added — first site in Taiwan
Show site
  • Yi-An Wu · New Taipei City, Taiwan
Nov 17, 2026
Primary completion
Aug 2026→Dec 2026
Nov 17, 2026
Study completion
Oct 2026→Dec 2026
Nov 17, 2026
Title
Effectiveness of Laser Acupuncture in ImprovingIrradiation on the Veins and Acupoints on Arterial Stiffness Amongin Patients With CardiorenalCardio-renal Metabolic Syndrome
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Not yet recruiting→Enrolling by invitation
    1 site added — first site in Taiwan
    Show site
    • Yi-An Wu · New Taipei City, Taiwan
    Primary completion Aug 2026→Dec 2026
    Study completion Oct 2026→Dec 2026
    Title Effectiveness of Laser Acupuncture in ImprovingIrradiation on the Veins and Acupoints on Arterial Stiffness Amongin Patients With CardiorenalCardio-renal Metabolic Syndrome
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07543211
Responsible party
Li-Yin Chien (Professor, National Yang Ming Chiao Tung University) — Principal investigator
First posted
Apr 21, 2026
Start date
May 1, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 17, 2026
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion